Bausch Health Companies | VRX - Loan Capital



Bausch Health Companies reported $20.86B in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Amgen USD 53.76B 253M Jun/2025
ANI Pharmaceuticals USD 608.35M 3.28M Jun/2025
Aurora Cannabis CAD 36.3M 3.89M Jun/2025
Bausch Health Companies USD 20.86B 369M Jun/2025
Biogen USD 6.28B 1.74B Jun/2025
Bristol-Myers Squibb USD 44.47B 1.69B Jun/2025
Canopy Growth CAD 289M 178.93M Jun/2025
Corcept Therapeutics USD 0 0 Mar/2025
Danaher USD 16.85B 877M Jun/2025
Drreddys Laboratories INR 59.47M 3.74B Jun/2025
Eli Lilly USD 34.18B 319.4M Jun/2025
Gilead Sciences USD 22.14B 6M Jun/2025
Novo Nordisk 87.3B 9.01B Jun/2025
Pacira USD 378.1M 3.2M Jun/2025
Perrigo USD 3.62B 24.2M Jun/2025
Prestige Brands USD 1.01B 256K Jun/2025
Supernus Pharmaceuticals USD 0 0 Dec/2024
Vertex Pharmaceuticals USD 112.8M 1.2M Dec/2024
Zoetis USD 5.23B 4M Jun/2025